Expleo Solutions Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: February 27, 2026, 1:39 am

Market Cap	1,191 Cr.
Current Price	768
Intrinsic Value	₹646.63
High / Low	1,371/686
Stock P/E	10.2
Book Value	453
Dividend Yield	6.51 %
ROCE	21.5 %
ROE	16.3 %
Face Value	10.0
PEG Ratio	13.40

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Expleo Solutions Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Visesh Infotecnics Ltd	125 Cr.	0.33	/		1.11	0.00 %	2.21 %	2.23 %	1.00
Mudunuru Ltd	48.4 Cr.	15.3	21.0/4.43		0.20	0.00 %	27.0 %	90.7 %	2.00
Naapbooks Ltd	98.5 Cr.	91.4	194/89.2	15.1	36.4	0.00 %	23.6 %	17.1 %	10.0
IB Infotech Enterprises Ltd	78.4 Cr.	612	612/140	49.0	26.7	0.16 %	38.5 %	35.4 %	10.0
Hit Kit Global Solutions Ltd	19.4 Cr.	3.59	3.59/0.91		2.24	0.00 %	2.14 %	2.15 %	2.00
Industry Average	17,155.54 Cr	455.44		107.00	121.92	0.71%	14.90%	21.00%	6.84

All Competitor Stocks of Expleo Solutions Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	240	231	225	234	250	255	252	259	258	256	260	283	279
Expenses	168	188	192	200	212	221	213	217	219	216	230	236	233
Operating Profit	72	43	33	34	38	34	39	42	39	40	30	47	46
OPM %	30%	19%	15%	14%	15%	13%	15%	16%	15%	16%	11%	17%	16%
Other Income	13	4	2	2	11	2	2	13	3	5	7	13	-6
Interest	1	0	1	1	1	1	1	1	1	1	1	1	0
Depreciation	7	7	8	8	8	9	9	10	12	8	8	7	7
Profit before tax	77	39	26	27	41	26	31	44	28	36	28	51	32
Tax %	28%	26%	22%	24%	16%	40%	23%	20%	30%	32%	28%	23%	31%
Net Profit	55	29	20	21	34	16	24	35	20	24	20	40	22
EPS in Rs	54.00	28.34	13.01	13.22	21.93	10.12	15.40	22.87	12.75	15.52	13.16	25.62	14.26

Last Updated: February 6, 2026, 1:16 am

Below is a detailed analysis of the quarterly data for Expleo Solutions Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

For Sales, as of Dec 2025, the value is 279.00 Cr.. The value appears to be declining and may need further review. It has decreased from 283.00 Cr. (Sep 2025) to 279.00 Cr., marking a decrease of 4.00 Cr..
For Expenses, as of Dec 2025, the value is 233.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 236.00 Cr. (Sep 2025) to 233.00 Cr., marking a decrease of 3.00 Cr..
For Operating Profit, as of Dec 2025, the value is 46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Sep 2025) to 46.00 Cr., marking a decrease of 1.00 Cr..
For OPM %, as of Dec 2025, the value is 16.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Sep 2025) to 16.00%, marking a decrease of 1.00%.
For Other Income, as of Dec 2025, the value is -6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Sep 2025) to -6.00 Cr., marking a decrease of 19.00 Cr..
For Interest, as of Dec 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Sep 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
For Depreciation, as of Dec 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 7.00 Cr..
For Profit before tax, as of Dec 2025, the value is 32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Sep 2025) to 32.00 Cr., marking a decrease of 19.00 Cr..
For Tax %, as of Dec 2025, the value is 31.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Sep 2025) to 31.00%, marking an increase of 8.00%.
For Net Profit, as of Dec 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Sep 2025) to 22.00 Cr., marking a decrease of 18.00 Cr..
For EPS in Rs, as of Dec 2025, the value is 14.26. The value appears to be declining and may need further review. It has decreased from 25.62 (Sep 2025) to 14.26, marking a decrease of 11.36.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 1:16 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	194	214	264	260	271	283	270	301	743	903	965	1,025	1,078
Expenses	155	177	210	219	231	230	217	231	618	703	816	859	915
Operating Profit	40	37	54	41	40	53	53	70	124	200	149	166	163
OPM %	20%	17%	20%	16%	15%	19%	20%	23%	17%	22%	15%	16%	15%
Other Income	10	2	6	1	13	6	8	5	6	16	7	16	18
Interest	2	2	0	0	0	0	1	1	1	2	3	3	3
Depreciation	6	5	4	5	6	6	6	6	19	28	34	39	30
Profit before tax	42	32	56	37	48	54	54	68	110	186	120	139	147
Tax %	29%	32%	34%	36%	33%	32%	26%	26%	39%	28%	24%	26%
Net Profit	30	22	37	24	32	36	40	50	68	134	90	103	106
EPS in Rs	29.26	20.53	34.68	22.29	29.86	33.79	38.92	49.20	66.01	130.59	58.27	66.52	68.56
Dividend Payout %	31%	117%	69%	108%	80%	0%	0%	0%	0%	6%	0%	75%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	-26.67%	68.18%	-35.14%	33.33%	12.50%	11.11%	25.00%	36.00%	97.06%	-32.84%	14.44%
Change in YoY Net Profit Growth (%)	0.00%	94.85%	-103.32%	68.47%	-20.83%	-1.39%	13.89%	11.00%	61.06%	-129.89%	47.28%

Expleo Solutions Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	17%
5 Years:	31%
3 Years:	11%
TTM:	4%

Compounded Profit Growth
10 Years:	17%
5 Years:	21%
3 Years:	14%
TTM:	6%

Stock Price CAGR
10 Years:	5%
5 Years:	16%
3 Years:	-8%
1 Year:	-22%

Return on Equity
10 Years:	22%
5 Years:	21%
3 Years:	20%
Last Year:	16%

Last Updated: September 5, 2025, 3:50 am

Balance Sheet

Last Updated: December 4, 2025, 1:13 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	10	11	11	11	11	11	10	10	16	16	16	16	16
Reserves	98	91	98	116	118	128	142	192	379	515	596	620	688
Borrowings	12	10	0	0	0	0	0	7	15	26	26	30	20
Other Liabilities	27	54	73	43	63	53	62	56	185	174	128	165	192
Total Liabilities	147	165	182	171	191	192	214	264	594	730	765	831	916
Fixed Assets	27	24	25	27	22	19	26	25	108	142	131	113	91
CWIP	1	1	0	0	0	0	0	0	6	6	5	0	0
Investments	0	0	0	0	0	0	0	0	0	0	15	0	0
Other Assets	119	139	157	144	169	173	188	239	480	582	614	719	825
Total Assets	147	165	182	171	191	192	214	264	594	730	765	831	916

Below is a detailed analysis of the balance sheet data for Expleo Solutions Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
For Reserves, as of Sep 2025, the value is 688.00 Cr.. The value appears strong and on an upward trend. It has increased from 620.00 Cr. (Mar 2025) to 688.00 Cr., marking an increase of 68.00 Cr..
For Borrowings, as of Sep 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 30.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 10.00 Cr..
For Other Liabilities, as of Sep 2025, the value is 192.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 165.00 Cr. (Mar 2025) to 192.00 Cr., marking an increase of 27.00 Cr..
For Total Liabilities, as of Sep 2025, the value is 916.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 831.00 Cr. (Mar 2025) to 916.00 Cr., marking an increase of 85.00 Cr..
For Fixed Assets, as of Sep 2025, the value is 91.00 Cr.. The value appears to be declining and may need further review. It has decreased from 113.00 Cr. (Mar 2025) to 91.00 Cr., marking a decrease of 22.00 Cr..
For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
For Other Assets, as of Sep 2025, the value is 825.00 Cr.. The value appears strong and on an upward trend. It has increased from 719.00 Cr. (Mar 2025) to 825.00 Cr., marking an increase of 106.00 Cr..
For Total Assets, as of Sep 2025, the value is 916.00 Cr.. The value appears strong and on an upward trend. It has increased from 831.00 Cr. (Mar 2025) to 916.00 Cr., marking an increase of 85.00 Cr..

Notably, the Reserves (688.00 Cr.) exceed the Borrowings (20.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	24	33	58	42	25	41	17	66	24	23	71	179
Cash from Investing Activity +	-1	-6	11	-14	-18	24	-7	-44	3	-37	-33	-51
Cash from Financing Activity +	-13	-11	-39	-31	-31	-26	-29	-3	-10	-7	-15	-87
Net Cash Flow	10	16	30	-2	-23	38	-19	19	17	-21	24	41

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	28.00	27.00	54.00	41.00	40.00	53.00	53.00	63.00	109.00	174.00	123.00	136.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	105	97	75	60	92	59	103	74	85	97	94	79
Inventory Days
Days Payable
Cash Conversion Cycle	105	97	75	60	92	59	103	74	85	97	94	79
Working Capital Days	68	23	-7	8	21	15	50	48	46	93	112	67
ROCE %	40%	29%	51%	31%	38%	40%	38%	39%	36%	39%	20%	21%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	56.17%	71.05%	71.05%	71.05%	71.05%	71.05%	71.05%	71.05%	71.05%	71.05%	71.05%	71.05%
FIIs	0.01%	0.15%	0.00%	0.03%	0.04%	0.06%	0.21%	0.49%	0.33%	0.09%	0.13%	0.32%
DIIs	4.74%	2.92%	2.73%	3.26%	2.37%	1.83%	1.78%	1.00%	0.91%	0.84%	0.84%	0.07%
Government	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	39.07%	25.87%	26.22%	25.67%	26.56%	27.06%	26.96%	27.46%	27.71%	28.03%	28.00%	28.57%
No. of Shareholders	20,671	21,831	25,651	27,179	29,462	29,083	28,506	27,530	28,556	28,491	29,017	29,158

Shareholding Pattern Chart

No. of Shareholders

Expleo Solutions Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Invesco India Multicap Fund	133,972	0.66	17.73	133,972	2025-04-22 15:56:58	0%
Invesco India Smallcap Fund	127,985	0.59	16.93	127,985	2025-04-22 15:56:58	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	66.52	58.27	86.27	52.58	49.20
Diluted EPS (Rs.)	66.52	58.27	86.27	52.58	49.20
Cash EPS (Rs.)	91.85	79.96	157.79	60.32	54.86
Book Value[Excl.RevalReserv]/Share (Rs.)	409.69	393.78	512.06	248.93	196.90
Book Value[Incl.RevalReserv]/Share (Rs.)	409.69	393.78	512.06	248.93	196.90
Revenue From Operations / Share (Rs.)	660.31	621.69	881.09	394.57	293.50
PBDIT / Share (Rs.)	117.18	100.42	210.93	78.85	73.42
PBIT / Share (Rs.)	91.86	78.73	183.73	71.11	67.75
PBT / Share (Rs.)	89.72	77.05	181.53	70.37	66.72
Net Profit / Share (Rs.)	66.52	58.27	130.60	52.58	49.20
NP After MI And SOA / Share (Rs.)	66.52	58.27	130.60	52.58	49.20
PBDIT Margin (%)	17.74	16.15	23.93	19.98	25.01
PBIT Margin (%)	13.91	12.66	20.85	18.02	23.08
PBT Margin (%)	13.58	12.39	20.60	17.83	22.73
Net Profit Margin (%)	10.07	9.37	14.82	13.32	16.76
NP After MI And SOA Margin (%)	10.07	9.37	14.82	13.32	16.76
Return on Networth / Equity (%)	16.23	14.79	25.50	21.12	24.98
Return on Capital Employeed (%)	20.76	18.48	33.48	27.11	33.16
Return On Assets (%)	12.42	11.82	18.33	15.65	19.08
Asset Turnover Ratio (%)	1.28	1.29	1.84	1.46	1.36
Current Ratio (X)	3.90	5.77	3.30	3.84	4.11
Quick Ratio (X)	3.90	5.77	3.30	3.84	4.11
Dividend Payout Ratio (NP) (%)	75.16	8.58	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	54.43	6.25	0.00	0.00	0.00
Earning Retention Ratio (%)	24.84	91.42	0.00	0.00	0.00
Cash Earning Retention Ratio (%)	45.57	93.75	0.00	0.00	0.00
Interest Coverage Ratio (X)	54.75	59.74	95.85	106.51	71.28
Interest Coverage Ratio (Post Tax) (X)	32.08	35.66	60.35	72.02	48.77
Enterprise Value (Cr.)	1006.97	1697.97	1111.70	1571.40	398.52
EV / Net Operating Revenue (X)	0.98	1.76	1.23	3.88	1.32
EV / EBITDA (X)	5.54	10.89	5.14	19.44	5.29
MarketCap / Net Operating Revenue (X)	1.21	1.95	1.40	4.27	1.76
Retention Ratios (%)	24.83	91.41	0.00	0.00	0.00
Price / BV (X)	1.94	3.08	2.41	6.77	2.62
Price / Net Operating Revenue (X)	1.21	1.95	1.40	4.27	1.76
EarningsYield	0.08	0.04	0.10	0.03	0.09

After reviewing the key financial ratios for Expleo Solutions Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
For Diluted EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
For Cash EPS (Rs.), as of Mar 25, the value is 91.85. This value is within the healthy range. It has increased from 79.96 (Mar 24) to 91.85, marking an increase of 11.89.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 660.31. It has increased from 621.69 (Mar 24) to 660.31, marking an increase of 38.62.
For PBDIT / Share (Rs.), as of Mar 25, the value is 117.18. This value is within the healthy range. It has increased from 100.42 (Mar 24) to 117.18, marking an increase of 16.76.
For PBIT / Share (Rs.), as of Mar 25, the value is 91.86. This value is within the healthy range. It has increased from 78.73 (Mar 24) to 91.86, marking an increase of 13.13.
For PBT / Share (Rs.), as of Mar 25, the value is 89.72. This value is within the healthy range. It has increased from 77.05 (Mar 24) to 89.72, marking an increase of 12.67.
For Net Profit / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
For PBDIT Margin (%), as of Mar 25, the value is 17.74. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 17.74, marking an increase of 1.59.
For PBIT Margin (%), as of Mar 25, the value is 13.91. This value is within the healthy range. It has increased from 12.66 (Mar 24) to 13.91, marking an increase of 1.25.
For PBT Margin (%), as of Mar 25, the value is 13.58. This value is within the healthy range. It has increased from 12.39 (Mar 24) to 13.58, marking an increase of 1.19.
For Net Profit Margin (%), as of Mar 25, the value is 10.07. This value exceeds the healthy maximum of 10. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.07. This value is within the healthy range. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
For Return on Networth / Equity (%), as of Mar 25, the value is 16.23. This value is within the healthy range. It has increased from 14.79 (Mar 24) to 16.23, marking an increase of 1.44.
For Return on Capital Employeed (%), as of Mar 25, the value is 20.76. This value is within the healthy range. It has increased from 18.48 (Mar 24) to 20.76, marking an increase of 2.28.
For Return On Assets (%), as of Mar 25, the value is 12.42. This value is within the healthy range. It has increased from 11.82 (Mar 24) to 12.42, marking an increase of 0.60.
For Asset Turnover Ratio (%), as of Mar 25, the value is 1.28. It has decreased from 1.29 (Mar 24) to 1.28, marking a decrease of 0.01.
For Current Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
For Quick Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 2. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 75.16. This value exceeds the healthy maximum of 50. It has increased from 8.58 (Mar 24) to 75.16, marking an increase of 66.58.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 54.43. This value exceeds the healthy maximum of 50. It has increased from 6.25 (Mar 24) to 54.43, marking an increase of 48.18.
For Earning Retention Ratio (%), as of Mar 25, the value is 24.84. This value is below the healthy minimum of 40. It has decreased from 91.42 (Mar 24) to 24.84, marking a decrease of 66.58.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 45.57. This value is within the healthy range. It has decreased from 93.75 (Mar 24) to 45.57, marking a decrease of 48.18.
For Interest Coverage Ratio (X), as of Mar 25, the value is 54.75. This value is within the healthy range. It has decreased from 59.74 (Mar 24) to 54.75, marking a decrease of 4.99.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.08. This value is within the healthy range. It has decreased from 35.66 (Mar 24) to 32.08, marking a decrease of 3.58.
For Enterprise Value (Cr.), as of Mar 25, the value is 1,006.97. It has decreased from 1,697.97 (Mar 24) to 1,006.97, marking a decrease of 691.00.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.76 (Mar 24) to 0.98, marking a decrease of 0.78.
For EV / EBITDA (X), as of Mar 25, the value is 5.54. This value is within the healthy range. It has decreased from 10.89 (Mar 24) to 5.54, marking a decrease of 5.35.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
For Retention Ratios (%), as of Mar 25, the value is 24.83. This value is below the healthy minimum of 30. It has decreased from 91.41 (Mar 24) to 24.83, marking a decrease of 66.58.
For Price / BV (X), as of Mar 25, the value is 1.94. This value is within the healthy range. It has decreased from 3.08 (Mar 24) to 1.94, marking a decrease of 1.14.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Expleo Solutions Ltd as of February 27, 2026 is: ₹641.75

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 27, 2026, Expleo Solutions Ltd is Overvalued by 16.44% compared to the current share price ₹768.00

Intrinsic Value of Expleo Solutions Ltd as of February 27, 2026 is: ₹646.63

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 27, 2026, Expleo Solutions Ltd is Overvalued by 15.80% compared to the current share price ₹768.00

Last 5 Year EPS CAGR: 0.76%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 35.17%, which is a positive sign. The company has higher reserves (290.85 cr) compared to borrowings (11.23 cr), indicating strong financial stability. The company has shown consistent growth in sales (359.23 cr) and profit (84.08 cr) over the years.	The stock has a high average Working Capital Days of 45.33, which may not be favorable. The stock has a high average Cash Conversion Cycle of 85.00, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Expleo Solutions Ltd:
1. Net Profit Margin: 10.07%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 20.76% (Industry Average ROCE: 14.9%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 16.23% (Industry Average ROE: 21%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 32.08
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 3.9
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 10.2 (Industry average Stock P/E: 107)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Expleo Solutions Ltd. is a Public Limited Listed company incorporated on 08/06/1998 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L64202TN1998PLC066604 and registration number is 066604. Currently Company is involved in the business activities of Writing , modifying, testing of computer program to meet the needs of a particular client excluding web-page designing. Company's Total Operating Revenue is Rs. 1024.80 Cr. and Equity Capital is Rs. 15.52 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
IT Consulting & Software	6A, Sixth Floor, Prince Infocity II, Chennai (Madras) Tamil Nadu 600096	Contact not found

Management
Name	Position Held
Mr. Ralph Franz Gillessen	Chairman & Non-Exe.Director
Mr. Phani Tangirala	Managing Director & CEO
Mr. Rajesh Krishnamurthy	Non Executive Director
Mr. Narayanan Subramaniam	Independent Director
Dr. Srivardhini Keshavamurthy Jha	Independent Director
Dr. Varadharajan Sridhar	Independent Director
Ms. Shalini Kalsi Kamath	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Expleo Solutions Ltd?

Expleo Solutions Ltd's intrinsic value (as of 27 February 2026) is ₹646.63 which is 15.80% lower the current market price of ₹768.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,191 Cr. market cap, FY2025-2026 high/low of ₹1,371/686, reserves of ₹688 Cr, and liabilities of ₹916 Cr.

What is the Market Cap of Expleo Solutions Ltd?

The Market Cap of Expleo Solutions Ltd is 1,191 Cr..

What is the current Stock Price of Expleo Solutions Ltd as on 27 February 2026?

The current stock price of Expleo Solutions Ltd as on 27 February 2026 is ₹768.

What is the High / Low of Expleo Solutions Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Expleo Solutions Ltd stocks is ₹1,371/686.

What is the Stock P/E of Expleo Solutions Ltd?

The Stock P/E of Expleo Solutions Ltd is 10.2.

What is the Book Value of Expleo Solutions Ltd?

The Book Value of Expleo Solutions Ltd is 453.

What is the Dividend Yield of Expleo Solutions Ltd?

The Dividend Yield of Expleo Solutions Ltd is 6.51 %.

What is the ROCE of Expleo Solutions Ltd?

The ROCE of Expleo Solutions Ltd is 21.5 %.

What is the ROE of Expleo Solutions Ltd?

The ROE of Expleo Solutions Ltd is 16.3 %.

What is the Face Value of Expleo Solutions Ltd?

The Face Value of Expleo Solutions Ltd is 10.0.